Target intelligence / Profile preview

Natural killer cells (NK cells) and macrophages (NK cells and macrophages)

Target
NK cells and macrophages
Molecular classification
Other
01

Overview

Natural killer (NK) cells and macrophages are distinct types of innate immune cells that play critical roles in the body's defense against pathogens and malignancies. NK cells are cytotoxic lymphocytes that recognize and kill stressed, virally infected, or transformed cells without prior sensitization, primarily through the release of perforin and granzymes (Source: NIH, StatPearls). Macrophages are versatile phagocytes derived from monocytes that clear cellular debris, present antigens to T cells, and orchestrate inflammatory responses through cytokine secretion and polarization into M1 (pro-inflammatory) or M2 (anti-inflammatory) states (Source: Nature Reviews Immunology). While these cell populations are frequently targeted in immunotherapy—such as through the use of checkpoint inhibitors, cytokines, or CAR-NK cells—they do not represent a single molecular target, receptor, or enzyme. Instead, they are complex cellular components of the immune system whose various surface receptors (e.g., CD16, CSF-1R, SIRPα) serve as the actual therapeutic targets for drug development (Source: PubMed, Journal of Hematology & Oncology). Consequently, the term 'NK cells and macrophages' refers to a cellular therapeutic focus rather than a specific biochemical target.

Other names
NK cellsNatural killer cellsMacrophagesM1/M2 macrophagesLarge granular lymphocytesMonocyte-derived macrophages
02

Mechanism of action

Modulation of innate immune cell activity, including activation of NK cell cytotoxicity via cytokine signaling, inhibition of macrophage 'don't eat me' signals (CD47/SIRPα), and polarization of macrophages from pro-tumorigenic M2 to anti-tumorigenic M1 phenotypes.

03

Biological functions

Immune responseCytotoxicityPhagocytosisAntigen presentationCytokine productionApoptosis
04

Disease associations

CancerInflammationInfectionAutoimmune disease
05

Safety considerations

Cytokine release syndrome (CRS)Macrophage activation syndrome (MAS)AnemiaAutoimmunityOff-target tissue damage
06

Interacting drugs

Aldesleukin

4 more in the full profile.

07

Biomarkers

CD56CD16CD14CD68CD163NCR1CSF1R

Beyond the preview

Go deeper on Natural killer cells (NK cells) and macrophages (NK cells and macrophages).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural killer cells (NK cells) and macrophages (NK cells and macrophages).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call